Skip to content

RNK Medical: what changed

BE 1002.918.929Other company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€58,375
2024 · €61,886-€3,511
Equity
€95,361
2024 · €51,986+€43,375
Cash
-
not filed
Balance sheet total
€138,275
2024 · €88,757+€49,518

Largest movements

2024 to 2025
Assets
  • Current investments +€45,021

    up €45,021 (+120%), from €37,669 to €82,689

  • Tangible fixed assets -€5,780

    down €5,780 (-16.8%), from €34,410 to €28,631

    of which Furniture and vehicles: -€5,140

  • Deferred charges and accrued income +€5,508

    up €5,508 (+132%), from €4,167 to €9,675

  • Receivables within one year +€4,769

    up €4,769 (+38.1%), from €12,511 to €17,280

    of which Trade receivables: +€4,769

Equity and liabilities
  • Reserves +€43,000

    up €43,000 (+86.0%), from €50,000 to €93,000

    of which Distributable reserves: +€93,000

  • Tax, wage and social debts +€3,525

    up €3,525 (+15.4%), from €22,883 to €26,408

  • Other debts +€1,998

    up €1,998 (+14.7%), from €13,600 to €15,598

Income statement
  • Purchases and services +€6,512

    up €6,512 (+6.3%), from €103,755 to €110,268

  • Gross operating margin -€4,990

    down €4,990 (-5.3%), from €93,994 to €89,004

  • Taxes -€975

    down €975 (-4.3%), from €22,883 to €21,908

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2024 €61,886
Gross operating margin -€4,990
Depreciation -€306
Other operating charges +€830
Other operating items -€174
Financial charges +€154
Taxes +€975
Result 2025 €58,375
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

Cash or the result is not a separate line in both sets of accounts. So the cash flow cannot be derived from them.

Every line side by side 41 lines
Line Code 2024 2025 Change %
Total assets 20/58 €88,757 €138,275 +€49,518 +55.8%
Fixed assets 21/28 €34,410 €28,631 -€5,780 -16.8%
Tangible fixed assets 22/27 €34,410 €28,631 -€5,780 -16.8%
Plant, machinery and equipment 23 €1,491 €852 -€640 -42.9%
Furniture and vehicles 24 €32,919 €27,779 -€5,140 -15.6%
Current assets 29/58 €54,347 €109,644 +€55,297 +102%
Amounts receivable within one year 40/41 €12,511 €17,280 +€4,769 +38.1%
Trade receivables 40 - €4,769 +€4,769
Other amounts receivable 41 €12,511 €12,511 = 0.0%
Current investments 50/53 €37,669 €82,689 +€45,021 +120%
Deferred charges and accrued income 490/1 €4,167 €9,675 +€5,508 +132%
Total equity and liabilities 10/49 €88,757 €138,275 +€49,518 +55.8%
Equity 10/15 €51,986 €95,361 +€43,375 +83.4%
Contributions 10/11 €100 €100 = 0.0%
Contributions outside capital 11 €100 - -€100
Other 1109/19 €100 - -€100
Reserves 13 €50,000 €93,000 +€43,000 +86.0%
Non-distributable reserves 130/1 €50,000 - -€50,000
Other 1319 €50,000 - -€50,000
Distributable reserves 133 - €93,000 +€93,000
Profit (loss) carried forward 14 €1,886 €2,261 +€375 +19.9%
Amounts payable 17/49 €36,771 €42,913 +€6,143 +16.7%
Amounts payable within one year 42/48 €36,771 €42,006 +€5,235 +14.2%
Trade debts 44 €288 - -€288
Suppliers 440/4 €288 - -€288
Taxes, remuneration and social security 45 €22,883 €26,408 +€3,525 +15.4%
Taxes 450/3 €22,883 €26,408 +€3,525 +15.4%
Other amounts payable 47/48 €13,600 €15,598 +€1,998 +14.7%
Accrued charges and deferred income 492/3 - €908 +€908
Goods, raw materials, services and sundry goods 60/61 €103,755 €110,268 +€6,512 +6.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €7,471 €7,778 +€306 +4.1%
Other operating charges 640/8 €1,524 €695 -€830 -54.4%
Non-recurring operating charges 66A - €174 +€174
Gross operating margin 9900 €93,994 €89,004 -€4,990 -5.3%
Operating profit (loss) 9901 €84,998 €80,358 -€4,640 -5.5%
Financial charges 65/66B €229 €75 -€154 -67.2%
Recurring financial charges 65 €229 €75 -€154 -67.2%
Profit (loss) for the period before taxes 9903 €84,769 €80,283 -€4,486 -5.3%
Income taxes 67/77 €22,883 €21,908 -€975 -4.3%
Profit (loss) for the period 9904 €61,886 €58,375 -€3,511 -5.7%
Profit (loss) for the period to be appropriated 9905 €61,886 €58,375 -€3,511 -5.7%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice
€262,745 to €348,771

Midpoint €298,589 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

Adjusted equity €95,361
Capitalised earnings €430,129 to €602,180
Indication €262,745 to €348,771

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€95,361
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€95,361

Capitalised earnings

net result for the year (9904)
2025
€58,375
excluding non-recurring income and charges
€58,549
2024
€61,886
Average result, excluding non-recurring income and charges
€60,218
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€430,129 / €501,817 / €602,180

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 21 November 2026 via checked.be.